Stefan N, Häring H-U, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7:313–24.
Tabaeian SP, Rezapour A, Azari S, Martini M, Saran M, Behzadifar M, Shahabi S, Sayyad A, Tahernejad A, Bragazzi N. Prevalence of non-alcoholic fatty liver disease in Iran: a systematic review and meta-analysis. J Clin Experimental Hepatol. 2024;14:101209.
Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, Ye Q, Huang DQ, Zhao C, Zhang J. 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:2809–17. e2828.
Li H, Shi Z, Chen X, Wang J, Ding J, Geng S, Sheng X, Shi S. Relationship between six insulin resistance surrogates and nonalcoholic fatty liver Disease among older adults: a cross-sectional study. Diabetes Metabolic Syndrome Obes 2023:1685–96.
Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol. 2016;11:451–96.
Article PubMed CAS Google Scholar
Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Reviews Gastroenterol Hepatol. 2022;19:60–78.
Berná G, Romero-Gomez M. The role of nutrition in non‐alcoholic fatty liver disease: pathophysiology and management. Liver Int. 2020;40:102–8.
Fernández T, Viñuela M, Vidal C, Barrera F. Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. PLoS ONE. 2022;17:e0263931.
Article PubMed PubMed Central Google Scholar
Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17:1689–96.
Doustmohammadian A, Amirkalali B, Esfandyari S, Motamed N, Maadi M, Shivappa N, Gholizadeh E, Hébert JR, Zamani F. The association between dietary inflammatory index (DII) scores and c-reactive protein (CRP) and nonalcoholic fatty liver disease (NAFLD) in a general population cohort. Clin Nutr ESPEN. 2024;60:156–64.
Ramírez-Vélez R, García‐Hermoso A, Izquierdo M, Correa‐Rodríguez M. The Dietary Inflammatory Index and hepatic health in the US adult population. J Hum Nutr Dietetics. 2022;35:968–79.
Zhang Z, Wang L, Lin Z, Yan W, Chen J, Zhang X, Ye W, Li J, Li Z. Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Front Nutr. 2023;10:1102660.
Article PubMed PubMed Central Google Scholar
Farhadnejad H, Tehrani AN, Jahromi MK, Teymoori F, Mokhtari E, Salehi-Sahlabadi A, Mirmiran P. The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults. BMC Gastroenterol. 2022;22:1–9.
Doustmohammadian A, Pishgar E, Clark CC, Sobhrakhshankhah E, Nikkhah M, Faraji AH, Motamed N, Mansourian MR, Amirkalali B, Maadi M. Empirically-derived dietary patterns in relation to non-alcoholic fatty liver diseases among adult participants in Amol, Northern Iran: a structural equation modeling Approach. Front Nutr 2022, 9.
Doustmohammadian A, Clark CC, Maadi M, Motamed N, Sobhrakhshankhah E, Ajdarkosh H, Mansourian MR, Esfandyari S, Hanjani NA, Nikkhoo M. Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). Sci Rep. 2022;12:2131.
Article PubMed PubMed Central CAS Google Scholar
Zhang X, Ruan J, He Y, Xu A, Fang Y, Zhang Q, Gu L, Liu X. Dietary inflammatory index and the risks of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Nutr. 2024;11:1388557.
Article PubMed PubMed Central Google Scholar
Polak-Szczybyło E, Tabarkiewicz J. Influence of dietary and lifestyle factors on levels of inflammatory markers (IL-6, IFN-γ and TNF-α) in obese subjects. Cent Eur J Immunol 2024, 49.
Kumar R, Porwal Y, Dev N, Kumar P, Chakravarthy S, Kumawat A. Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian indians: a cross-sectional study. J Family Med Prim Care. 2020;9:390.
Article PubMed PubMed Central Google Scholar
Soltanieh S, Salavatizadeh M, Poustchi H, Yari Z, Mansour A, Khamseh ME, Malek M, Alaei-Shahmiri F, Hekmatdoost A. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM). Heliyon 2023, 9.
Doustmohammadian A, Nouri Saeidlou S, Esfandyari S, Gholizadeh E, Maadi M, Motamed N, Ajdarkosh H, Khoonsari M, Clark CC, Zamani F. Dietary acid load (DAL), glycated hemoglobin A1c (HbA1c), and metabolic syndrome (MeS) mediate the association of the adherence to the dietary approaches to stopping hypertension (DASH) and mediterranean diet (MeD) with nonalcoholic fatty liver disease. Front Nutr. 2022;9:921415.
Article PubMed PubMed Central Google Scholar
Aslani Z, Sadeghi O, Heidari-Beni M, Zahedi H, Baygi F, Shivappa N, Hébert JR, Moradi S, Sotoudeh G, Asayesh H. Association of dietary inflammatory potential with cardiometabolic risk factors and diseases: a systematic review and dose–response meta-analysis of observational studies. Diabetol Metab Syndr. 2020;12:1–40.
Yang X, Tao S, Peng J, Zhao J, Li S, Wu N, Wen Y, Xue Q, Yang CX, Pan XF. High-sensitivity C‐reactive protein and risk of type 2 diabetes: a nationwide cohort study and updated meta‐analysis. Diab/Metab Res Rev. 2021;37:e3446.
DeFilippis AP, Blaha MJ, Martin SS, Reed RM, Jones SR, Nasir K, Blumenthal RS, Budoff MJ. Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2013;227:429–36.
Article PubMed PubMed Central CAS Google Scholar
Flisiak-Jackiewicz M, Bobrus-Chociej A, Wasilewska N, Lebensztejn DM. From nonalcoholic fatty liver Disease (NAFLD) to Metabolic Dysfunction-Associated fatty liver disease (MAFLD)—New Terminology in Pediatric patients as a step in Good Scientific Direction? J Clin Med. 2021;10:924.
Article PubMed PubMed Central CAS Google Scholar
Little TD, Card NA, Bovaird JA, Preacher KJ, Crandall CS. Structural equation modeling of mediation and moderation with contextual factors. Model Contextual Eff Longitud Stud. 2007;1:207–30.
Zamani F, Sohrabi M, Alipour A, Motamed N, Saeedian FS, Pirzad R, Abedi K, Maadi M, Ajdarkosh H, Hemmasi G. Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: a population based study. Arch Iran Med. 2014;17:0–0.
Doustmohammadian A, Clark CC, Maadi M, Motamed N, Sobhrakhshankhah E, Ajdarkosh H, Mansourian MR, Esfandyari S, Hanjani NA, Nikkhoo M. Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). Sci Rep. 2022;12:1–9.
Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:S1220–8.
Pearson T, Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.
Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 1999;7:42–58.
Kiefte-de Jong JC, Li Y, Chen M, Curhan GC, Mattei J, Malik VS, Forman JP, Franco OH, Hu FB. Diet-dependent acid load and type 2 diabetes: pooled results from three prospective cohort studies. Diabetologia. 2017;60:270–9.
Article PubMed CAS Google Scholar
Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR. Designing and developing a literature-derived population-based dietary inflammatory index. Public Health Nutr. 2014;17:1689–96.
Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13:654–62.
Hébert JR, Shivappa N, Wirth MD, Hussey JR, Hurley TG. Perspective: the Dietary Inflammatory Index (DII)-Lessons learned, improvements made, and future directions. Adv Nutr. 2019;10:185–95.
Article PubMed PubMed Central Google Scholar
Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310:2061–8.
Article PubMed PubMed Central CAS Google Scholar
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.
留言 (0)